Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Beth F. Son, Mary; L. Murray, Nancy; G. Friedman, Kevin; C. Young, Cameron; M. Newhams, Margaret; R. Feldstein, Leora; L. Loftis, Laura; M. Tarquinio, Keiko; R. Singh, Aalok; M. Heidemann, Sabrina; L Soma, Vijaya; J. Riggs, Becky; C. Fitzgerald, Julie; Kong, Michele; Doymaz, Sule; S. Giuliano, John; Keenaghan, Michael; R. Hume, Janet; V. Hobbs, Charlotte; E. Schuster, Jennifer; N. Clouser, Katharine; W. Hall, Mark; Smith, Lincoln; M. Horwitz, Steven; P. Schwartz, Stephanie; Irby, Katherine; T. Bradford, Tamara; B. Maddux, Aline; Babbitt, Christopher; M. Rowan, Courtney; E. McLaughlin, Gwenn; H. Yager, Phoebe; Maamari, Mia; H. Mack, Elizabeth; L. Carroll, Christopher; Montgomery, Vicki; Halasa, Natasha; Z. Cvijanovich, Natalie; M. Coates, Bria; E. Rose, Charles; W. Newburger, Jane; M. Patel, Manish; G. Randolph, Adrienne

doi:10.1056/nejmoa2102605

Public

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Published in New England Journal of Medicine • Jun 16, 2021

Authors:

Mary Beth F. Son

Nancy L. Murray

Kevin G. Friedman

Abstract

BACKGROUND: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. METHODS: We analyzed surveillance data on inpatients younger than 21 years of age who had MIS-C and were admitted to 1 of 58 U.S. hospit...

Subject

Medicine

Intensive care medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!